Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Study of ACE-86225106 to Treat Patients With Advanced Solid Tumors
Phase 1
Recruiting
- Conditions
- Solid Tumor, AdultBRCA1 MutationBRCA2 MutationOvarian CancerBreast CancerProstate Cancer
- Interventions
- First Posted Date
- 2024-04-24
- Last Posted Date
- 2025-05-18
- Lead Sponsor
- Acerand Therapeutics (Shanghai) Limited
- Target Recruit Count
- 298
- Registration Number
- NCT06380660
- Locations
- 🇨🇳
Chongqing Cancer Hospital, Chongqing, Chongqing, China
🇨🇳Henan Cancer Hospital, Zhengzhou, Henan, China
🇨🇳Jinan Central Hospital, Jinan, Shandong, China
News
No news found